Nuveen Asset Management »

Candel Therapeutics shares owned by Nuveen Asset Management

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Nuveen Asset Management from 13F filings

Historical chart of Nuveen Asset Management investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Nuveen Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Nuveen Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.4M 382k 6.20

More positions owned by Nuveen Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Mastercard Incorporated Cl A (MA)
JPMorgan Chase & Co. (JPM)
Costco Wholesale Corporation (COST)
Nushares Etf Tr Get Opp Etf (NUGO)
Visa Com Cl A (V)

View all positions for Nuveen Asset Management

Top funds holding Candel Therapeutics

Northpond Ventures
BlackRock
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Sands Capital Ventures
Nuveen Asset Management
Susquehanna International
Northern Trust
Citadel Advisors
Bridgeway Capital Management
Jane Street
HB Wealth Management
Charles Schwab Investment Management

View all funds holding Candel Therapeutics